Regulating autologous adult stem cells: the FDA steps up
- PMID: 22056136
- DOI: 10.1016/j.stem.2011.09.013
Regulating autologous adult stem cells: the FDA steps up
Abstract
The Food and Drug Administration (FDA) has sought an injunction to prevent a US-based company from offering an autologous adult stem cell treatment for musculoskeletal and spinal injuries. Given the alarming number of clinics promoting stem-cell-based interventions, the outcome of this case could have wide-ranging implications.
Copyright © 2011 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
